Structure–Function Activity Relationships of Cariprazine Analogues with Distinct G Protein versus β-Arrestin Activities at the Dopamine D3 Receptor
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00721 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Bradley M Keegan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse ─ Intramural Research Program, Nati…. Hauptthemen laut MEDLINE: Receptors, Dopamine D3, beta-Arrestins, Piperazines, GTP-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Intramural Research Program, Lundbeck Foundation.
Abstract (Originalsprache)
Psychostimulant use disorder (PSUD) remains an unmet medical need, with no FDA-approved pharmacotherapies currently available. The dopamine D3 receptor (D3R), due to its selective expression in mesolimbic reward circuits, has emerged as a compelling target for PSUD intervention. We used cariprazine (1a), a D3R-preferring antipsychotic that reduces cocaine-related behaviors in preclinical models, as a scaffold for the synthesis of a library of novel derivatives. We employed BRET-based assays to functionally characterize their effects on G protein and β-arrestin2 signaling at D3R. Structure-function relationship analyses revealed that modifications to the phenylpiperazine moiety of cariprazine are the key determinants of D3R efficacy, potentially through diverse interactions with transmembrane segment 5. Moreover, certain substitutions to this aromatic primary pharmacophore appear to confer D3R/D2R functional divergence. These findings offer key mechanistic insights and inform the rational design of next-generation bitopic ligands with optimized signaling properties for the treatment of PSUD and related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse ─ Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 2122…
- Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse ─ Intramural Research Program, National Institutes of Health, 333 Cassell Dr…
ORCID-Profile: Bradley M Keegan, Alessandro Bonifazi, Emma S Gogarnoiu, Amy Hauck Newman, Lei Shi
Förderung
- Intramural Research Program
- Lundbeck Foundation
Zitieren
APA
Keegan, B. M., Vogt, C. D., Chen, L., Nosko, R. J., Saab, E., Bonifazi, A., Gogarnoiu, E. S., Shaik, A. B., Newman, A. H., & Shi, L. (2025). Structure–Function Activity Relationships of Cariprazine Analogues with Distinct G Protein versus β-Arrestin Activities at the Dopamine D3 Receptor. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00721
Vancouver
Keegan BM, Vogt CD, Chen L, Nosko RJ, Saab E, Bonifazi A, et al. Structure–Function Activity Relationships of Cariprazine Analogues with Distinct G Protein versus β-Arrestin Activities at the Dopamine D3 Receptor. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00721
BibTeX
@article{Keegan2025,
author = {Keegan, Bradley M and Vogt, Caleb D and Chen, Li and Nosko, Renee J and Saab, Elizabeth and Bonifazi, Alessandro and Gogarnoiu, Emma S and Shaik, Anver Basha and Newman, Amy Hauck and Shi, Lei},
title = {Structure–Function Activity Relationships of Cariprazine Analogues with Distinct G Protein versus β-Arrestin Activities at the Dopamine D3 Receptor},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00721}
}
EUVIMED